COMMUNIQUÉS West-GlobeNewswire

Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain
22/01/2025
Pain marks the second therapeutic area for Cullgen’s lead protein degrader CG001419 SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company [...]
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
22/01/2025
DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has [...]
NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players
22/01/2025
Registry will use HeartFlow FFR CT and Plaque Analysis to help inform strategies for prevention, earlier detection and improved care for former NFL athletes at high risk for coronary artery disease MOUNTAIN VIEW, Calif [...]
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
21/01/2025
MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]
Kraig Biocraft Laboratories Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization
21/01/2025
ANN ARBOR, Mich., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based fibers, announces that it has secured $10 [...]
NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director
21/01/2025
TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“ NurExone ” or the “ Company ”), a developer of exosome-based therapies for regenerative [...]
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
21/01/2025
OsStic ® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually ( 1) ; arrangement leverages Sanara’s existing call points and commercial [...]
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments
21/01/2025
Elizabeth Taylor Appointed Chief Financial Officer; Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort [...]
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
21/01/2025
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . [...]
AdCare Rhode Island Welcomes Community to Free Educational Event on the Use of Medications to Treat Addiction
21/01/2025
NORTH KINGSTOWN, R.I., Jan. 21, 2025 (GLOBE NEWSWIRE) -- In response to Rhode Island’s ongoing addiction and overdose crisis, AdCare Rhode Island , a leading provider of substance use and co-occurring disorder treatment [...]
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
21/01/2025
WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments [...]
Oculis Publishes Notification of Major Changes in Voting Rights
21/01/2025
ZUG, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes in Voting Rights. Attachment Notification of Major Changes in Voting Rights - Íslandsbanki (21 Jan 2025)
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
21/01/2025
LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a forward-thinking innovator in health and wellness solutions, is pleased to announce that FINRA has approved a dividend to its [...]
Rising from the Ashes: Ivy En Rose MedSpa Reopens in San Francisco, Exemplifying Strength and Community Spirit
21/01/2025
Beloved MedSpa Overcomes Devastating Fire and Challenges to Continue Serving the Bay Area SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- In a remarkable display of resilience and determination, Ivy En Rose MedSpa is [...]
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
21/01/2025
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
LifeLabs Named Canada’s Most Trusted Health Diagnostic Service Provider for Third Consecutive Year by BrandSpark Most Trusted Awards
21/01/2025
Toronto, Ontario, Jan. 21, 2025 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that it has been named Canada’s Most Trusted Health Diagnostic Service Provider for the third year in a row by the 2025 BrandSpark Most [...]
Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal
21/01/2025
Acquisition of distributor business expands Intuitive’s investment and footprint in Europe SUNNYVALE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive [...]
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
21/01/2025
LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Argentum 47, Inc. (OTC PINK: ARGQ) (“Argentum” or the “Company”) today announced a series of transformative developments, including the acquisition of Marelius Biopharma [...]
Pharming Group to convene Extraordinary General Meeting of Shareholders
21/01/2025
Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on [...]

Pages